CMP as on 06-Jul-22 15:50₹ 639.30
Turnover (lac)₹ 295
Prev. Close₹ 643.70
Day's Vol (shares)₹ 46,092
Day's Range (₹)
CMP as on06-Jul-22 15:29₹ 640.00
Turnover (lac)₹ 45
Prev. Close₹ 646.35
Day's Vol (shares)₹ 4,077
As per industry sales data, Nexavar registered sales of USD 69.7 million for the year ending December 2021.
Natco Pharma update on lawsuit for Glatiramer Acetate Injection
Patent IN 298645 covers a Process to prepare CHLORANTRANILIPROLE (CTPR) that is set to expire on December 6, 2025, the company said.
On 30 May 2022
Natco Pharma Ltd is quoting at Rs 824.45, up 3.41% on the day as on 12:54 IST on the NSE. The stock is down 0.74% in last one year as c
Natco Pharma Ltd is quoting at Rs 782.5, down 0.76% on the day as on 13:24 IST on the NSE. The stock jumped 21.12% in last one year as
Lenalidomide capsules are available in 5mg, 1Omg, 15mg, and 25mg strengths.
Natco Pharma rose 4% to Rs 881.35 after the company announced the launch of the first generic version of Revlimid (lenalidomide capsule
Natco Pharma Ltd is quoting at Rs 800.25, down 2.99% on the day as on 13:24 IST on the NSE. The stock jumped 17.07% in last one year as
PAT after considering minority interest was Rs80.40 crore for Q3.
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity